KLINISCHER DOSIERPLAN VON INS-3001
European patent · EP4284384 · In force
Register entry
- Publication number
- EP4284384
- Application number
- EP22702445
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 26, 2022
- Published
- Dec 6, 2023
- Granted
- Mar 25, 2026
- Protection ends at the latest
- Jan 25, 2042
- Next annual fee due
- Jan 31, 2027
- IPC classes
- A61K 31/6615 (2006.01)A61K 9/00 (2006.01)A61K 9/08 (2006.01)A61K 47/02 (2006.01)A61P 9/10 (2006.01)A61P 9/14 (2006.01)A61P 43/00 (2006.01)
- Priority
- EP 21153605 26.01.2021
- PCT application
- PCT/EP2022/051694 26.01.2022
- PCT publication
- WO2022/161980 04.08.2022
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 25, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 25.03.2026
Parties
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.